Artificial Intelligence (AI) in Biotechnology Market is driven by growing demand for drug discovery
The Global Artificial Intelligence (AI) in Biotechnology Market is estimated to be valued at US$ 7.11 Bn in 2024 and is expected to exhibit a CAGR of 19% over the forecast period 2024 to 2031. Key Takeaways Key players operating in the Artificial Intelligence (AI) in Biotechnology are AstraZeneca, Bristol-Myers Squibb, Gilead Sciences, Inc., Sanofi, Abbott Laboratories, Biogen, Pfizer, Inc.,...
0 التعليقات 0 المشاركات 734 مشاهدة 0 معاينة